Chlorpropamide Overview Categories 18 Hormones and other endocrine drugs and contraceptives18.7 Antidiabetics18.7.2 Oral hypoglycemics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Glibenclamide Manufacturers of Glibenclamide Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Glibenclamide's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 50 to 100 mg75 (75)24 hourlyOrallyMaintanance dose.1-2 divided doses 5-7 days after the initial therapy250 mg250 (250)24 hourlyPOWith breakfast. Paedriatic Dosage (20kg) Not Recommended in this Age Group Neonatal Dosage (3kg) 125 to 250 mg190 (187.5)24 hourlyFor central D.I. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Glibenclamide Back to top Manufacturers of Chlorpropamide in Pakistan Geofman Jinnah Pfizer Zafa Back to top Previous Drug Generic - Next Drug Generic
Chlorpropamide Overview Categories 18 Hormones and other endocrine drugs and contraceptives18.7 Antidiabetics18.7.2 Oral hypoglycemics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Glibenclamide Manufacturers of Glibenclamide Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Glibenclamide's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 50 to 100 mg75 (75)24 hourlyOrallyMaintanance dose.1-2 divided doses 5-7 days after the initial therapy250 mg250 (250)24 hourlyPOWith breakfast. Paedriatic Dosage (20kg) Not Recommended in this Age Group Neonatal Dosage (3kg) 125 to 250 mg190 (187.5)24 hourlyFor central D.I. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Glibenclamide Back to top Manufacturers of Chlorpropamide in Pakistan Geofman Jinnah Pfizer Zafa Back to top Previous Drug Generic - Next Drug Generic